|
1
|
Bradl M and Linington C: Animal model of
demyelination. Brain Pathol. 6:303–311. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Polman CH, Dijkstra CD, Sminia T and
Koetsier JC: Immunohistological analysis of macrophages in the
central nervous system of Lewis rats with experimental autoimmune
encephalomyelitis. J Neuroimmunol. 11:215–21. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mendel 1, Keriero de Rosbo N and Ben-Nun
A: A myelin oligodendrocyte glycoprotein peptide induces typical
chronic experimental autoimmune encephalomyelitis in H-2b mice:
Fine specificity and T cell receptor V beta expression of
encephalitogenic T cells. Eur J Immunol. 25:1951–1959. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pál E, Yamamura T and Tabira T: Autonomic
regulation of experimental autoimmune encephalomyelitis in IL-4
knockout mice. J Neuroimmunol. 100:149–155. 1999. View Article : Google Scholar
|
|
5
|
Baumann N and Pham-Dinh D: Biology of
oligodendrocyte and myelin in the mammalian central nervous system.
Physiol Rev. 81:871–927. 2001.PubMed/NCBI
|
|
6
|
Wang H, Munger KL, Reindl M, O'Reilly EJ,
Levin LI, Berger T and Ascherio A: Myelin oligodendrocyte
glycoprotein antibodies and multiple sclerosis in healthy young
adults. Neurology. 71:1142–1146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roscoe WA, Welsh ME, Carter DE and Karlik
SJ: VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide
induced EAE. J Neuroimmunol. 209:6–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berard JL, Wolak K, Fournier S and David
S: Characterization of relapsing-remitting and chronic forms of
experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia.
58:434–445. 2010.
|
|
9
|
Slavin A, Ewing C, Liu J, Ichikawa M,
Slavin J and Bernard CC: Induction of a multiple sclerosis-like
disease in mice with an immunodominant epitope of myelin
oligodendrocyte glycoprotein. Autoimmunity. 28:109–120. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanamori M, Kawaguchi T, Nigro JM,
Feuerstein BG, Berger MS, Miele L and Pieper RO: Contribution of
Notch signaling activation to human glioblastoma multiforme. J
Neurosurg. 106:417–427. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rao P and Segal BM: Experimental
autoimmune encephalomyelitis. Methods Mol Med. 102:363–375.
2004.PubMed/NCBI
|
|
12
|
Steinman L: Antigen-specific therapy of
multiple sclerosis: The long-sought magic bullet.
Neurotherapeutics. 4:661–665. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oukka M: Interplay between pathogenic Th17
and regulatory T cells. Ann Rheum Dis. 66(Suppl 3): iii87–iii90.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edwards LJ, Robins RA and Constantinescu
CS: Th17/Th1 phenotype in demyelinating disease. Cytokine.
50:19–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benson JM, Stuckman SS, Cox KL, Wardrop
RM, Gienapp IE, Cross AH, Trotter JL and Whitacre CC: Oral
administration of myelin basic protein is superior to myelin in
suppressing established relapsing experimental autoimmune
encephalomyelitis. J Immunol. 162:6247541999.
|
|
16
|
Qu N, Zhou XY, Han L, Wang L, Xu JX, Zhang
T, Chu J, Chen Q, Wang JZ, Zhang Q and Tian Q: Combination of PPT
with LiCl treatment prevented bilateral ovariectomy-induced
hippocampal-dependent cognition deficit in rats. Mol Neurobiol. Dec
23;Epub ahead of print. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lehuen A, Diana J, Zaccone P and Cooke A:
Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol.
10:501–513. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lisak RP: Neurodegeneration in multiple
sclerosis: Defining the problem. Neurology. 68:S5–S12; discussion
S43-S54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goverman J: Autoimmune T cell responses in
the central nervous system. Nat Rev Immunol. 9:393–407. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miller AH, Maletic V and Raison CL:
Inflammation and its discontents: The role of cytokines in the
pathophysiology of major depression. Biol Psychiatry. 65:732–741.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Murphy AC, Lalor SJ, Lynch MA and Mills
KH: Infiltration of Th1 and Th17 cells and activation of microglia
in the CNS during the course of experimental autoimmune
encephalomyelitis. Brain Behav Immun. 24:641–651. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Friese MA and Fugger L: Pathogenic CD8(+)
T cells in multiple sclerosis. Ann Neurol. 66:132–141. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy
N and Mills KH: T cells in multiple sclerosis and experimental
autoimmune encephalomyelitis. Clin Exp Immunol. 162:1–11. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saxena A, Martin-Blondel G, Mars LT and
Liblau RS: Role of CD8 T cell subsets in the pathogenesis of
multiple sclerosis. FEBS Lett. 585:3758–3763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sobottka B, Harrer MD, Ziegler U, Fischer
K, Wiendl H, Hünig T, Becher B and Goebels N: Collateral bystander
damage by myelin-directed CD8+ T cells causes axonal loss. Am J
Pathol. 175:1160–1166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Niederkorn JY: Emerging concepts in CD8(+)
T regulatory cells. Curr Opin Immunol. 20:327–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
